Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 5/20 | 0.56 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.56 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.52 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 2/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | MTOR | P42345 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.42 |
| ▸ | EGFR | P00533 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | CHAT | P28329 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30364986 | 1.00 | NFE2L2 (0.56) | NFE2L2TRPA1HSD11B1CHRNA7MAOB | |
| SCHEMBL14703725 | 1.00 | NFE2L2 (0.56) | NFE2L2TRPA1HSD11B1CHRNA7MAOB | |
| SCHEMBL6737776 | 1.00 | NFE2L2 (0.56) | NFE2L2TRPA1HSD11B1CHRNA7MAOB | |
| SCHEMBL3328957 | 0.93 | HSD11B1 (0.54) | NFE2L2TRPA1HSD11B1CHRNA7NPC1 | |
| SCHEMBL3328961 | 0.93 | HSD11B1 (0.54) | NFE2L2TRPA1HSD11B1CHRNA7NPC1 | |
| SCHEMBL297691 | 0.87 | HSD11B1 (0.62) | NFE2L2HSD11B1CHRNA7NPC1MEN1 | |
| SCHEMBL1751871 | 0.87 | HSD11B1 (0.62) | NFE2L2HSD11B1CHRNA7NPC1MEN1 | |
| SCHEMBL8900317 | 0.87 | HSD11B1 (0.62) | NFE2L2HSD11B1CHRNA7NPC1MEN1 | |
| SCHEMBL31613215 | 0.87 | HSD11B1 (0.62) | NFE2L2HSD11B1CHRNA7NPC1MEN1 | |
| SCHEMBL28706684 | 0.87 | HDAC2 (0.46) | NFE2L2TRPA1HSD11B1CHRNA7MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12291593-B2 | Compounds for use in catalyst compositions for the production of polyolefins | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2025-05-06 | — | — | US | disclosed |
| EP-4031592-B1 | COMPOUNDS FOR USE IN CATALYST COMPOSITIONS FOR THE PRODUCTION OF POLYOLEFINS | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2025-04-30 | — | — | EP | disclosed |
| CN-114423769-B | Compounds in catalyst compositions for the production of polyolefins | SABIC环球技术有限责任公司 | 2024-04-26 | — | — | CN | disclosed |
| US-20230234900-A1 | METHODS OF ARENE ALKENYLATION | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2023-07-27 | — | — | US | disclosed |
| US-20230234900-A1 | METHODS OF ARENE ALKENYLATION | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2023-07-27 | — | — | US | disclosed |
| CN-114195610-B | Synthesis method of E-type internal olefin compound | 海南大学 | 2023-07-14 | — | — | CN | disclosed |
| WO-2023062575-A1 | CYCLIC VINYL SULFONE COMPOUNDS AS WRN INHIBITORS | IDEAYA BIOSCIENCES, INC. (US) | 2023-04-20 | — | — | WO | disclosed |
| US-20220356275-A1 | COMPOUNDS FOR USE IN CATALYST COMPOSITIONS FOR THE PRODUCTION OF POLYOLEFINS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2022-11-10 | — | — | US | disclosed |
| EP-4031592-A1 | COMPOUNDS FOR USE IN CATALYST COMPOSITIONS FOR THE PRODUCTION OF POLYOLEFINS | SABIC Global Technologies B.V. (NL) | 2022-07-27 | — | — | EP | disclosed |
| CN-114423769-A | Compounds for use in catalyst compositions for the production of polyolefins | SABIC环球技术有限责任公司 | 2022-04-29 | — | — | CN | disclosed |
| EP-0629609-A1 | Process for the preparation of Alkoxyiminoacetamide derivatives and an intermediate therefor | SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. (JP) | 1994-12-21 | — | — | EP | disclosed |
| US-5371222-A | Intermediates | SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) | 1994-12-06 | — | — | US | disclosed |
| US-5371223-A | Controlling phytopathogens | SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) | 1994-12-06 | — | — | US | disclosed |
| US-5315025-A | Acrylate ethers | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1994-05-24 | — | — | US | disclosed |
| US-5286894-A | Phenyl acrylic acid derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1994-02-15 | — | — | US | disclosed |
| US-5185342-A | ALKOXYIMINOACETAMIDE DERIVATIVES AND THEIR USE AS FUNGICIDES | SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) | 1993-02-09 | — | — | US | disclosed |
| EP-0178826-B1 | FUNGICIDES | ZENECA LIMITED (GB) | 1991-12-18 | — | — | EP | disclosed |
| EP-0431328-A2 | Fungicides | ZENECA LIMITED (GB) | 1991-06-12 | — | — | EP | disclosed |
| EP-0398692-A2 | Alkoxyiminoacetamide derivatives and their use as fungicides | SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. (JP) | 1990-11-22 | — | — | EP | disclosed |
| EP-0178826-A2 | Fungicides | ZENECA LIMITED (GB) | 1986-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220356275-A1 | COMPOUNDS FOR USE IN CATALYST COMPOSITIONS FOR THE PRODUCTION OF POLYOLEFINS | RPLP0, RPS20, RPS10 | NFE2L2 2039/4885TRPA1 1692/4885HSD11B1 1831/4885 |
| US-20230234900-A1 | METHODS OF ARENE ALKENYLATION | CYBB, CBR3, AHR | NFE2L2 102/4885TRPA1 1407/4885HSD11B1 560/4885 |
| US-12291593-B2 | Compounds for use in catalyst compositions for the production of polyolefins | RPLP0, RPS20, RPS10 | NFE2L2 2039/4885TRPA1 1692/4885HSD11B1 1831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.